Drug Type Cell therapy |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Orca Biosystems, Inc.Startup |
Active Organization Orca Biosystems, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Lymphoblastic Leukemia | Phase 1 | - | Orca Biosystems, Inc.Startup | - |
Acute Myeloid Leukemia | Phase 1 | - | Orca Biosystems, Inc.Startup | - |
Mixed phenotype acute leukemia | Phase 1 | - | Orca Biosystems, Inc.Startup | - |
Myelodysplastic Syndromes | Phase 1 | - | Orca Biosystems, Inc.Startup | - |